Accessibility Menu
Stevanato Group S.p.A. logo

Stevanato Group S.p.A.

(NYSE) STVN

Current Price$19.20
Market Cap$5.23BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-1%
5 Year-1%
1 Year-25%
1 Month+12%
Stevanato Group S.p.A. last closing stock price
MetricPriceDate
Last closeUSD 19.172026-07-17
Stevanato Group S.p.A. stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-2.14%USD 19.592026-07-10
1 month+12.37%USD 17.062026-06-17
3 month+23.89%USD 15.472026-04-17
Year to date-4.38%USD 20.052025-12-31
1 year-24.52%USD 25.402025-07-17
3 year-39.2%USD 31.532023-07-18
5 year-1.08%USD 19.382021-07-16
Since inception-1.07%USD 19.382021-07-16

Stevanato Group S.p.A. Financials at a Glance

Market Cap

$5.23BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€1.20B

Net Income (TTM)

€140.95M

EPS (TTM)

$0.60

P/E Ratio

31.91

Dividend

$0.06

Beta (Volatility)

0.87 (Low)

Price

$19.20

Volume

4,254

Open

$19.76

Previous Close

$19.20

Daily Range

$19.20 - $19.76

52-Week Range

$12.89 - $28.00

Estimated Earnings Date

Aug 4, 2026

STVN News

No articles available.

STVN: Motley Fool Moneyball Superscore

59

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Stevanato Group S.p.A.

Stevanato Group S.p.A. is dedicated to engineering, manufacturing, and distributing integrated solutions for the pharmaceutical and healthcare sectors. Established in 1949, the company offers a diverse range of products, including containment solutions, drug delivery systems, and medical devices.

Products and Services
  • Containment solutions for pharmaceuticals
  • Drug delivery systems and medical devices
  • Specialized machinery for packaging and inspection
Growth Outlook
  • Projected growth in the global pharmaceutical market supports demand
  • Expansion into emerging markets enhances revenue potential
  • Investment in R&D aims to innovate product offerings
Financial Highlights
  • Recent quarterly revenue of €273.57 million, showing resilience
  • Net income of €28.03 million reflects strong operational efficiency
  • TTM gross profit margin of 29.01% indicates solid profitability
Stevanato Group S.p.A. operates in the healthcare sector, focusing on providing essential solutions that cater to the evolving needs of the pharmaceutical industry. The company's commitment to innovation and quality positions it well for future growth, particularly as the global demand for healthcare solutions continues to rise. Recent financial performance highlights a robust revenue stream and effective cost management, contributing to a healthy net income. The strategic focus on research and development further enhances the company's potential to capture market share and drive long-term value for investors.
AI Generated • Jun 21, 2026

Industry

Life Sciences Tools and Services

Sector

Health Care

CEO

Franco Stevanato

Website

www.stevanatogroup.com

Headquarters

Piombino Dese, PD 35017, IT

STVN Financials

Key Financial Metrics (TTM)

Gross Margin

29.01%

Operating Margin

16.57%

Net Income Margin

11.75%

Return on Equity

9.63%

Return on Capital

9.36%

Return on Assets

5.46%

Earnings Yield

3.13%

Dividend Yield

0.32%

Payout Ratio

0.04%

Stock Overview

Market Cap

$5.23BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

273.00M

Volume

4.25K

Avg. Volume

404.21K

Financials (TTM)

Gross Profit

€348.16M

Operating Income

€198.80M

EBITDA

€294.22M

Operating Cash Flow

€260.08M

Capital Expenditure

-€267.18M

Free Cash Flow

-€7.11M

Cash & ST Invst.

€112.73M

Total Debt

€448.52M

Stevanato Group S.p.A. Performance Analysis

Stevanato Group S.p.A. annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 1,033,822,4163.6%
20232023-12-31EUR 1,173,393,14413.5%
20242024-12-31EUR 1,194,225,5361.8%
20252025-12-31EUR 1,338,811,70812.1%
Stevanato Group S.p.A. sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-309.1%
Q32025-09-308.3%
Q42025-12-3113.2%
Q12026-03-31-20.3%
Stevanato Group S.p.A. annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 0.57-5.4%
20232023-12-31EUR 0.594.8%
20242024-12-31EUR 0.47-20.9%
20252025-12-31EUR 0.5823.1%
Stevanato Group S.p.A. sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3010.0%
Q32025-09-3018.2%
Q42025-12-3130.8%
Q12026-03-31-41.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

€273.57M

+6.6%

Gross Profit

€75.18M

+7.6%

Gross Margin

27.48%

N/A

Market Cap

$5.23BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$870.80K

N/A

Employees

6,010

N/A

Net Income

€28.03M

+5.7%

EBITDA

€65.06M

+13.8%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

€112.73M

+24.3%

Total Debt

€448.52M

+14.0%

Accounts Receivable

€506.66M

+3.9%

Inventory

€294.36M

+12.5%

Long Term Debt

€323.76M

+3.5%

Short Term Debt

€124.75M

+54.7%

Return on Assets

5.46%

N/A

Return on Invested Capital

9.82%

N/A

Free Cash Flow

€4.77M

-83.0%

Operating Cash Flow

€75.49M

-24.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BLCOBausch + Lomb Corporation
$16.26-3.27%
TFXTeleflex Incorporated
$134.61-0.45%
MMSIMerit Medical Systems, Inc.
$73.99-2.06%
CHEChemed Corporation
$510.03+1.70%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$6.53-0.02%
NFLXNetflix
$68.95-0.07%
NOKNokia
$10.12-0.03%
PATHUiPath
$12.15+0.01%

Questions About STVN

What is the current price of Stevanato Group S.p.A.?

Stevanato Group S.p.A. is trading at $19.20 per share.

What is the 52-week range for Stevanato Group S.p.A.?

Over the past 52 weeks, Stevanato Group S.p.A. has traded between $12.89 and $28.00.

How much debt does Stevanato Group S.p.A. have?

As of the most recent reporting period, Stevanato Group S.p.A. reported total debt of €516.78M.

How much cash does Stevanato Group S.p.A. have on hand?

Stevanato Group S.p.A. reported €128.67M in cash and cash equivalents in its most recent financial results.

What is Stevanato Group S.p.A.’s dividend yield?

Stevanato Group S.p.A. currently has a dividend yield of 0.32%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services